MHealth Market Share & Trends Will Hit USD 151.57 Billion By 2025 : Grand View Research Inc.

San Francisco, 28 June 2019: The Report mHealth Market Analysis Report By Participants (Mobile Operators, Device Vendors, Healthcare Providers), By Service (Diagnosis, Monitoring, Healthcare Systems), And Segment Forecasts, 2018 – 2025

The global mHealth market size is expected to reach USD 151.57 billion by 2025, progressing at a CAGR 25.7% over the forecast period, according to a new report by Grand View Research, Inc. The market is majorly driven by growing geriatric population, rising prevalence of chronic diseases, and increasing penetration of smartphones and internet connections. Technological advancements are leading to product innovations in the area of mHealth, which in turn will bode well for the market.

Growing inclination towards preventive healthcare and subsequently rising subscription to mHealth apps have been working in favor of the market. mHealth apps exhibit several features that offer healthcare benefits to healthcare providers as well as patients. mHealth apps provide accessibility to health related information. mHealth apps also ensure continuous communication between patients and providers, thereby allowing providers to diagnose, recommend, and monitor patients without even seeing them in person.

Adoption of smartphones with subscription to mHealth apps among adult population in the U.S. is rising in order to maintain routine check. For instance, according to a paper published in NCBI in February 2016, around 91.0% of adult population in the U.S. own a mobile phone, with 61.0% of them possessing smartphones.

Access Research Report of MHealth Market @ www.grandviewresearch.com/industry-analysis/mhealth-market

Further Key Findings From the Report Suggest:

• In 2017, monitoring services held the largest revenue share owing to growing adoption of mhealth solutions for monitoring health conditions such as diabetes
• The healthcare system strengthening services segment is likely to register the highest CAGR of 27.7% over the forecast period
• Healthcare providers will be the most promising participant segment during the forecast period, mainly due to adoption of digital technology by healthcare facilities in order to optimize care management process
• In 2017, Europe accounted for the largest revenue share in the market owing to rising research initiatives in the area of mHealth
• Key players in this space include Apple Inc.; AT&T; Airstrip Technologies; Allscripts Healthcare Solutions; Google Inc; Orange; Soft Serve; mQure; and Samsung Electronics.

Browse more reports of this category by Grand View Research at: www.grandviewresearch.com/industry/healthcare-it

Grand View Research has segmented the global mHealth market on the basis of services, participants and region:

mHealth Services Outlook (Revenue, USD Million, 2014 – 2025)

• Monitoring services
  • Independent aging solutions
  • Chronic disease management and post-acute care services
• Diagnosis services
• Healthcare systems strengthening services
• Others

mHealth Participants Outlook (Revenue, USD Million, 2014 – 2025)

• Mobile operators
• Device vendors
• Content players
• Healthcare providers

mHealth Regional Outlook (Revenue, USD Million, 2014 – 2025)

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Access Press Release of MHealth Market @ www.grandviewresearch.com/press-release/global-mHealth-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

 

Biomaterials Market Is Likely To Up Demand At A USD 2.38 Billion By 2026 : Grand View Research Inc.

San Francisco, 28 June 2019: The Report Biomaterials Market Size, Share & Trends Analysis Report By Product (Natural, Metallic, Ceramics, Polymers), By Application (Cardiovascular, Orthopedics, Plastic Surgery), And Segment Forecasts, 2018 – 2025

The global biomaterial market size is expected to reach USD 250.4 billion by 2025, according to a new report by Grand View Research, Inc., exhibiting a CAGR of 14.7% during the forecast period. Technological innovations in the field of biomaterials are leading to development of advanced products, which in turn is working in favor of the market. Widening base of geriatric population worldwide and subsequent rise in prevalence of cardiovascular and orthopedic disorders are providing a fillip to the market.

Biomaterials are now widely used in healthcare fields such as cardiovascular, orthopedic, dental, plastic medical procedure, wound repair, ophthalmology and neurological conditions. Furthermore, they are utilized in different advanced healthcare technologies such as cosmetic surgeries, tissue engineering, medical implants, and advanced drug delivery.

Geographically, North America held the largest share in the biomaterials market in 2017. The growth of the regional market can be attributed to various technological and mechanical progressions, high utility of medical services, growing geriatric population, and higher medical insurance coverage.

Some of the prominent companies operating in the market are DSM; BASF SE; Evonik Industries AG.; Berkeley Advanced Biomaterials, Inc.; CAM Bioceramics BV; Carpenter Technology Corporation; Invibio Ltd.; Zimmer Biomet Holdings, Inc.; Covalon Technologies Ltd.; Collagen Matrix, Inc.; Medtronic, Inc.; Purac Biomaterials; Ticona GmbH; Osteotech, Inc.; and Bayer AG

Access Research Report of Biomaterials Market @ www.grandviewresearch.com/industry-analysis/biomaterials-industry

Further key findings from the report suggest:

• Rapid advancements in the field of genetics and increasing usage of biomaterials in oncology, personal genomics, and agrigenomics are expected to drive the market
• Factors such as high cost of instruments and platforms, ethical concerns, and ambiguous reimbursement policies in some countries are estimated to negatively impact the growth of the market
• Based on products, the natural segment is anticipated to register the highest CAGR of close to 16.7% during the forecast period
• On the basis of application, orthopedics was the most prominent segment in 2017, accounting for more than 20.0% of the market revenue
• There are many industrial scale healthcare projects and genome research projects launched in North American & European countries for improving the adoption of advanced healthcare technologies
• Strong presence of a raft of biomaterial technology providers, better infrastructure, patient awareness, and good healthcare facilities in these regions are aiding market growth.

Browse more reports of this category by Grand View Research at: www.grandviewresearch.com/industry/biotechnology

Grand View Research has segmented the global biomaterials market based on products, application, technique, end use, and region:

Biomaterials Products Outlook (Revenue, USD Million, 2014 – 2025)

• Metallic
• Natural
• Ceramics
• Polymers

Biomaterials Application Outlook (Revenue, USD Million, 2014 – 2025)

• Cardiovascular
  • Sensors
  • Stents
  • Guidewires
  • Implantable Cardiac Defibrillators
  • Pacemakers
  • Vascular Grafts
  • Others
• Ophthalmology
  • Synthetic Corneas
  • Intraocular Lens
  • Contact Lens
  • Ocular Tissue Replacement
  • Others
• Dental
  • Tissue Regeneration Materials
  • Dental Implants
  • Bone Grafts & Substitutes
  • Dental Membranes
  • Others
• Orthopedic
  • Joint Replacement biomaterials
  • Orthobiologics
  • Bioresorbable Tissue Fixation Products
  • Viscosupplementation
  • Spine Biomaterial
  • Others
• Wound Healing
  • Fracture Healing Device
  • Adhesion Barrier
  • Skin Substitutes
  • Internal Tissue Sealant
  • Surgical Hemostats
  • Others
• Tissue Engineering
• Plastic Surgery
  • Facial Wrinkle Treatment
  • Soft Tissue Fillers
  • Craniofacial Surgery
  • Bioengineered Skins
  • Peripheral Nerve Repair
  • Acellular Dermal Matrices
  • Others
• Neurology
  • Neural Stem Cell Encapsulation
  • Shunting Systems
  • Hydrogel Scaffold For CNS Repair
  • Cortical Neural Prosthetics
  • Others
• Others

Biomaterials Regional Outlook (Revenue, USD Million, 2014 – 2025)

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East Africa

Access Press Release of Biomaterials Market @ www.grandviewresearch.com/press-release/global-biomaterials-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

 

Nurse Call System Market Expected To Fuel Industry Growth With USD 2.38 Billion By 2026 : Grand View Research Inc.

San Francisco, 28 June 2019: The Report Nurse Call System Market Size, Share & Trends Analysis Report By Technology (Wired Communication Equipment, Wireless Communication Equipment), By End Use, And Segment Forecasts, 2019 – 2026

The global nurse call system market size is expected to reach USD 2.38 billion by 2026, according to a new report by Grand View Research, Inc. It is projected to expand at a CAGR of 9.9% during the forecast period. Increasing support for digital healthcare, government penalties for hospital readmissions, and demand for resident and patient safety are expected to drive the demand.

In addition, continuous technology advancements to bring in a new level of communication enabling the widest range of applications configuration to home cares, hospitals, or residential facilities are also expected to upsurge the demand for nurse call system. In April 2015, Mircom launched MiCare wireless nurse call system, designed to enable its integration with cloud technology..

Hospitals have a major share of the nurse call system market owing to the patient flow and increasing chronic and emergency case patients. Moreover, researchers are filing patents for technologies that offer uninterrupted communication. In December 2018, Ascom Holdings AG has received the approval certificate from the U.S. Food and Drug Administration (FDA) as class II 510(k) for Digistat Smart Central software solution increasing the scope of the Ascom Healthcare to expand their presence in the U.S. hospitals.

North America was the largest regional market owing to the establishment of separate certification and coding system and introduction of new integrated solutions by key players. For instance, in October 2018, Tunstall Healthcare acquired Kanayo Software Inc., and EWII Telecare to expand its Connected Health solutions. The acquisition provided Tunstall with expertise in Software and App products in health and social care.

Access Research Report of Nurse Call System Market @ www.grandviewresearch.com/industry-analysis/nurse-call-system-equipments-industry

Further key findings from the report suggest:

• Wired communication equipment led the market in 2018 owing to the early adoption of technology and continuous innovations such as integration Wi-Fi cordless telephone, IP DECT, and radio pocket pager for greater efficiency and safety
• Asia Pacific is the fastest growing market owing to the huge population base, high technology adoption rate, and government funding for digital health. The demand for real-time nurse call systems is increasing owing to the need to offer better patient response time and avoiding patient falls
• Market participants are constantly evolving the traditional systems and are incorporating newer techniques and devices. In January 2019, the Hill Rom launched its LINQ mobile application for an improvement in communication between the patient and caregiver formerly in U.S. and Canada with further expansion to Europe
• Some key players in the nurse call system market include Hill-Rom Holding, Inc.; Tyco SimplexGrinnell; Ascom Holding; Honeywell International, Inc.; Rauland-Borg Corporation; TekTone Sound & Signal Mfg., Inc.; Stanley Healthcare; Azure Healthcare; West-Com Nurse Call Systems, Inc.; and Critical Alert Systems LLC.

Browse more reports of this category by Grand View Research at: www.grandviewresearch.com/industry/medical-devices

Grand View Research has segmented the global nurse call system market on the basis of technology, end use, and regions:

Nurse Call System Technology Outlook (Revenue, USD Million, 2015 – 2026)

• Wired Communication Equipment
• Wireless Communication Equipment

Nurse Call System End Use Outlook (Revenue, USD Million, 2015 – 2026)

• Hospitals and Clinics
• Outpatient Departments (OPDs)
• Assisted Living Facilities (ALFs)
• Ambulatory Care Services
• Skilled Nursing Facilities

Nurse Call System Regional Outlook (Revenue, USD Million, 2015 – 2026)

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Access Press Release of Nurse Call System Market @ www.grandviewresearch.com/press-release/global-nurse-call-system-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Biopharmaceutical Third Party Logistics (3PL) Market Size Was Valued At USD 120.64 Billion By 2025 : Grand View Research Inc.

San Francisco, 28 June 2019: The Report Biopharmaceutical Third Party Logistics (3PL) Market Size, Share & Trends Analysis Report By Supply Chain (Cold Chain, Non-cold Chain), By Service, By Region, And Segment Forecasts, 2019 – 2025

The global biopharmaceutical third party logistics market size is expected to reach USD 120.64 billion by 2025, at a CAGR 4.9% over the forecast period, according to a new report by Grand View Research, Inc. The market for biopharmaceutical third party logistics (3PL) is majorly driven by rising demand for temperature controlled logistic services to transport biologics in various regions and growing distribution networks of biopharmaceutical companies to improve their sales. Rising adoption of automated storage and retrieval systems in the emerging countries is an ongoing trend in the pharmaceutical logistics companies that has gained a significant traction..

Furthermore, the trend of shifting from small molecule drugs to biopharmaceuticals, mainly vaccines and biologics, is projected to drive the market. Since, these small molecule drugs are temperature sensitive products, demand for temperature controlled transportation and storage increases and thus is responsible for the market growth. As of now, the pharmaceutical sales through distributors have grown from USD 304.6 billion in 2013 to USD 440.2 billion in 2016. However, the average number of manufacturers per distributor had declined from 1,474 in 2014 to 1,211 in 2016. This data depicts that there is an increase in quantity of pharmaceutical products being distributed, and thus, is expected to surge the demand for 3PL services.

Additionally, environmental concerns and cost have caused a slight shift in the means of transport used for commercial product, moving from airway to seaway shipping and in roadways from truck to intermodal (both rail and truck). The intermodal transport is majorly used by these pharmaceutical companies to reduce the carbon footprint. The ongoing trend shows that the pharmaceutical manufacturers have shifted towards sea freight to reduce the cost and risk factor. Although for cold chain products, the companies still prefer air freight. However, some of the large pharmaceutical companies are planning to transport 70% of their products via ocean freight including cold chain products.

Access Research Report of Biopharmaceutical Third Party Logistics (3PL) Market @ www.grandviewresearch.com/industry-analysis/biopharmaceutical-third-party-logistics-3pl-market

Further key findings from the report suggest:

• In 2018, non-cold chain logistics held the largest market share in terms of revenue owing to the sales of a large number of drugs that do not require any temperature control
• Cold chain logistics segment is expected to register the faster CAGR over the forecast period owing to the demand for biologics, such as cellular therapies, vaccines, and test kits
• Warehousing and storage held the largest market share among the types of services in 2018
• Asia pacific expected to emerge with the fastest CAGR over the forecast period owing to adoption of medicines from aging population and shift of drug sales from brand manufacturers to generic
• Key players operating in the biopharmaceutical third party logistics market include DHL International GmbH., SF Express, United Parcel Service of America, Inc, AmerisourceBergen Corporation, DB Schenker, Kuehne and Nagel, Kerry logistics network limited and Agility

Browse more reports of this category by Grand View Research at: www.grandviewresearch.com/industry/pharmaceuticals

Grand View Research has segmented the global biopharmaceutical third party logistics market on the basis of service, participant, and region:

Biopharmaceutical Third Party Logistics Supply Chain Outlook (Revenue, USD Million, 2014 – 2025)

• Cold Chain
• Non-cold Chain

Biopharmaceutical Third Party Logistics Service Outlook (Revenue, USD Million, 2014 – 2025)

• Transportation
  • Air Freight
  • Sea Freight
  • Overland
• Warehousing and Storage
• Others

Biopharmaceutical Third Party Logistics Regional Outlook (Revenue, USD Million, 2014 – 2025)

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Access Press Release of Biopharmaceutical Third Party Logistics (3PL) Market @ www.grandviewresearch.com/press-release/global-biopharmaceutical-third-party-logistics-3pl-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Antacids Market Is Expected To Reach USD 7.91 Billion By 2025 : Grand View Research Inc.

San Francisco, 28 June 2019: The Report Antacids Market Size, Share & Trends Analysis Report By Dosage Form (Tablet, Liquid), By Distribution Channel (Retail, Hospital, Online Pharmacy), By Region (APAC, Europe, North America), And Segment Forecasts, 2019 – 2025

The global antacid market size is expected to reach USD 7.91 billion by 2025, according to a new report by Grand View Research, Inc. It is projected to expand at a CAGR of 3.9% over the forecast period. The trend of self-medication for occasional heartburn is one of the major factors driving the market.

Growing geriatric population is expected to positively impact the overall market for antacid. According to the United Nations Department of Economic And Social Affairs (DESA), the global elderly population (60 years and above), was around 962 million in 2017. This number is expected to grow at the fastest rate in Latin America with 71% increase in population aged 60 and over, followed by Asia with 66%, Africa with 64%, North America with 41%, and Europe with 23%.

Key players operating in antacid market focus on product enhancement to cater to patient requirements, such as changing the dosage form into chewable tablets, powder, and jelly. Also, these players are involved in collaborations and acquisitions to expand their market presence. For instance, in 2017, Pfizer, Inc. entered into a strategic agreement with AstraZeneca to acquire one of the antacid brands, Neksium for a value of INR 75 crores in India to boost its product portfolio.

The easy availability of antacids over-the-counter offer growth opportunities for the sales of overall market. Some of the key players areGlaxoSmithKline plc; AstraZeneca; Pfizer, Inc.; Sun Pharmaceuticals Industries Ltd.; Dr. Reddy’s Laboratories Ltd.; Bayer AG; Takeda Pharmaceutical Company Limited.

Access Research Report of Antacids Market @ www.grandviewresearch.com/industry-analysis/antacids-market

Further key findings from the report suggest:

• In 2017, tablet segment led the antacid market due to high efficacy compared to other dosage forms. Liquid is anticipated to be the fastest growing segment due to its palatable taste and preferred choice for children and elderly population
• Retail pharmacy led the distribution channel segment due its accessibility and availability. Online pharmacy is anticipated to be the fastest growing segment due to growing adoption of Pharma 3.0 and consumer awareness
• Asia Pacific is estimated to be the largest and fastest growing region over the forecast period due to presence of key players such as GlaxoSmithKline plc; Pfizer Inc.; and Abbott among others
• North America held the second largest market share in 2017 owing to increasing prevalence of different digestive disorders
• Some of the key companies operating in this market are GlaxoSmithKline plc; Bayer AG; Boehringer Ingelheim International GmbH; Dr. Reddy’s Laboratories Ltd.; Reckitt Benckiser Group plc; Sun Pharmaceuticals Ltd.; Sanofi; Takeda Pharmaceutical Company Limited; Pfizer Inc.; and Procter & Gamble.

Browse more reports of this category by Grand View Research at: www.grandviewresearch.com/industry/pharmaceuticals

Grand View Research has segmented the global antacid market based on dosage form, distribution channel, and region:

Antacid Dosage Form Outlook (Revenue, USD Million, 2014 – 2025)

• Tablet
• Liquid
• Others

Antacid Distribution Channel Outlook (Revenue, USD Million, 2014 – 2025)

• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy

Antacid Regional Outlook (Revenue, USD Million, 2014 – 2025)

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Access Press Release of Antacids Market @ www.grandviewresearch.com/press-release/global-antacids-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Radiofrequency Ablation Devices Market Poised To Augment The Industry At $6.7 Billion By 2026 : Grand View Research Inc.

San Francisco, 28 June 2019: The Report Radiofrequency Ablation Devices Market Size, Share & Trends Analysis Report By Product (Disposable, Capital, Reusable Equipment), By Application, By Region, And Segment Forecasts, 2019 – 2026

The global radiofrequency ablation devices market size is anticipated to reach USD 6.7 billion by 2026, according to a new report by Grand View Research, Inc. It is expected to register a CAGR of 11.6% during the forecast period. Increasing preference for minimally invasive surgeries, growing geriatric population, and rise in healthcare spending for better disease treatment are expected to propel the growth..

According to the American Society of Plastic Surgeons, by the end of 2015, 15.9 million minimally invasive cosmetic surgeries were performed in U.S. According to the Centers for Disease Control and Prevention (CDC), more than six million laparoscopic procedures are performed across the U.S. and EU countries every year.

Radiofrequency ablation is now used early in the management of patients suffering from atrial tachycardia or atrial fibrillation or other kinds of coronary disease. This factor is anticipated to boost the market growth. According to the American College of Cardiology Foundation, coronary heart disease is the leading cause of deaths (43.8%) in U.S., followed by stroke (16.8%), heart failure (9.0%), high BP (9.4%), and other CVDs (17.9%). By 2035, the total cost of CVD is expected to reach USD 1.1 trillion and is projected to affect 45.1% (130 million) adults in U.S.

Radiofrequency ablation can also be used to reduce neck pain, low-back pain, arthritis, and pelvic and peripheral nerve pain. According to WebMD LLC., RFA has been proven to be effective in more than 70% of the patients experiencing pain. Pain relief from RFA can last from six to 12 months or even a year.

Access Research Report of Radiofrequency Ablation Devices Market @ www.grandviewresearch.com/industry-analysis/radiofrequency-ablation-devices-market

Further key findings from the report suggest:

• Disposable equipment held the largest market share in 2018 due to reduced morbidity and mortality and the ability of the equipment to provide treatment in an outpatient setting. For example, Radiopaque RF cannula (Halyard Worldwide, Inc) provides improved visualization under fluoroscopy for accurate positioning, resulting in a targeted treatment
• Cardiology and cardiac rhythm management is anticipated to be the fastest-growing segment during the forecast period due to disease prevalence, growing awareness, and adoption of minimally invasive operations. In 2012 RFA-Academia launched an initiative to increase awareness in Europe and to teach endoscopists safe and justified application of RFA to reduce the disease burden
• North America is anticipated to continue leading the radiofrequency ablation devices market during the forecast period due to high healthcare expenditure, incidence of cardiac disease and cancer, and the number of patients suffering from pain
• Asia Pacific is expected to witness significant growth over the next decade due to increasing demand for minimally invasive procedures to treat cancer and growing awareness regarding the benefits of ablation method over the conventional surgical procedures
• Some of the key players are Boston Scientific Corporation; Medtronic; Stryker; Cosman Medical, Inc.; St. Jude Medical; Smith & Nephew; Johnson & Johnson (J&J) Services, LLC; and AngioDynamics.

Browse more reports of this category by Grand View Research at: www.grandviewresearch.com/industry/medical-devices

Grand View Research has segmented the global radiofrequency ablation devices market based on type and region:

Radiofrequency Ablation Devices Product Outlook (Revenue, USD Million, 2015 – 2026)

• Disposable Equipment
• Capital Equipment
• Reusable Equipment

Radiofrequency Ablation Devices Mode of Delivery Outlook (Revenue, USD Million, 2015 – 2026)

• Surgical Oncology
• Cardiology & Cardiac Rhythm Management
• Cosmetology
• Gynecology
• Pain Management

Radiofrequency Ablation Devices Regional Outlook (Revenue, USD Million, 2015 – 2026)

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Access Press Release of Radiofrequency Ablation Devices Market @ www.grandviewresearch.com/press-release/global-radiofrequency-ablation-devices-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Separation Systems for Commercial Biotechnology Market Projected To Dominate The Industry With USD 39.47 Billion By 2025 : Grand View Research Inc.

San Francisco, 27 June 2019: The Report Separation Systems for Commercial Biotechnology Market Analysis By Methods (Microarray, Lab-on-a-chip, Chromatography, Flow Cytometry, Biochip), By Application, And Segment Forecasts, 2018 – 2025

The global separation system for commercial biotechnology market is expected to reach USD 39.47 billion by 2025, according to a new report by Grand View Research, Inc. Intensive research in the field of biotechnology to develop advanced products is expected to boost growth in the coming years. Moreover, contributions of leading industrial entities in this sector for accelerating commercial production is anticipated to drive the market.

Government bodies are providing funds to small & medium enterprises for the development of novel technologies. This is expected to enhance the efficiency of large-scale upstream bioprocessing systems used for separation & purification of biomolecules. Such instruments are extensively used for production of food & cosmetics, agriculture, plastics, and chemicals.

Moreover, the popularity of technologically advanced single-use bioprocessing systems in various industries, such as agro-processing, chemical & plastics is contributing toward the growth of the upstream processing sector. Rising cases of chronic & severe metabolic & genetic disorders are ultimately increasing the demand of potential therapeutics. Rising demand for biopharmaceuticals is likely to result in lucrative growth.

Furthermore, changing healthcare reforms and public -private collaborations among industrial players, government, and research institutions are expected to improve the technological aspects of separation methods. Thus, in turn, is anticipated to significantly render the growth of commercial separation market over the forecast period.

Access Research Report of Separation Systems for Commercial Biotechnology Market @ www.grandviewresearch.com/industry-analysis/separation-systems-for-commercial-biotechnology-market

Further Key Findings from the Report Suggest:

• Conventional separation techniques are estimated to account for the largest revenue share owing to technological advancements in the segment
• However, modern methods are anticipated to grow at the fastest pace in the coming years due to rise in adoption of these technologies
• Technological advancements in product capabilities are anticipated to boost the market
• Pharmaceutical industry accounted for the largest revenue share owing to higher usage of systems for commercialization of therapeutics
• Rising prevalence of various chronic disorders is indirectly boosting growth
• North America dominated the market with adequate administration support, extensive research, and well-established industrial framework
• Asia Pacific region is expected to exhibit fastest growth over the forecast period owing to progressive industrialization and favorable government support
• Major players include Shimadzu Corporation; PerkinElmer, Inc.; Agilent Technologies; GE Healthcare; Thermo Fisher Scientific; Bio-Rad Laboratories, Inc.; bioMérieux SA; Merck & Co., Inc.; WATERS; Hitachi Koki Co., Ltd.; QIAGEN; Sartorius; BD; Danaher; and Miltenyi Biotec
• Companies are entering into collaborations with academic institutions, private, and public entities to accelerate product development and launch novel systems

Browse more reports of this category by Grand View Research at: www.grandviewresearch.com/industry/biotechnology

Grand View Research has segmented the separation systems for commercial biotechnology market on the basis of methods, application, and region:

Method Outlook (Revenue, USD Million; 2014 – 2025)

• Modern methods
  • Microarray
  • Lab-on-a-chip
  • Biochip
  • Magnetic separation
• Conventional methods
  • Chromatography
  • Flow cytometry
  • Membrane filtration
  • Electrophoresis
  • Centrifugation

Application Outlook (Revenue, USD Million; 2014 – 2025)

• Pharmaceutical
  • Vaccines
  • Proteins
  • Hormones/Insulin
  • Enzymes
  • Human Blood Plasma Fractionation
  • Mammalian Cell Cultures
• Food & Cosmetics
• Agriculture
• Others

Regional Outlook (Revenue, USD Million; 2014 – 2025)

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa (MEA)

Access Press Release of Separation Systems for Commercial Biotechnology Market @ www.grandviewresearch.com/press-release/global-separation-systems-for-commercial-biotechnology-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Ocular Implants Market Expected To Bolster The Industry Growth With USD 18.4 Billion By 2025 : Grand View Research Inc.

San Francisco, 27 June 2019: The Report Ocular Implants Market Analysis By Product (Intraocular Lenses, Corneal Implants, Glaucoma Implants, Ocular Prosthesis), By Application (Glaucoma, Drug Delivery), By End-use, And Segment Forecasts, 2018 – 2025

The global ocular implants market is expected to reach USD 18.4 billion by 2025, growing at a CAGR of 6.7%, according to a new report by Grand View Research, Inc. The increase in incidence of cataract is a major factor for this market’s growth. Cataract has been identified as a leading cause of blindness globally, and this has encouraged many industry players and government organizations to develop ocular implants.

Technological advancements and increasing acceptance of vision correction coupled with fast adoption of intraocular lenses in cataract surgeries are the factors supporting this market’s growth. For instance, a new collagen glaucoma implant that inhibits the formation of scar and is biodegradable has been developed.

Eye research institutes play a vital role in the technological advancements associated with intraocular lenses. The advent of various advance intraocular lenses and increase in competition amongst players for development of better lenses as well as rise in investment on eye research institutes by government and nongovernment organizations are anticipated to fuel market growth. Hence, owing to the rise in number of clinical trials pertaining to these lenses and increase in government expenditure on R&D, the market is expected to witness lucrative growth in the intraocular segment.

In addition, increase in ophthalmic disorders and demand for better eye implants are creating abundant growth opportunities for this market, which is expected to increase the number of players in the market.

Access Research Report of Ocular Implants Market @ www.grandviewresearch.com/industry-analysis/ocular-implants-market

Further Key Findings From the Report Suggest:

• Intraocular lenses, corneal implants, orbital implants, glaucoma implants, and ocular prosthesis are the key segments analyzed in this study. The glaucoma implants segment was identified as the largest and is expected to grow at a CAGR of over 6.0% during the forecast period.
• North America is one of the most lucrative regions for ocular implants due to growing aging population and easy availability of reimbursement facilities, which boost the regional market.  The U.S. is most dominating country in this region, owing to a large population having supportive insurance coverage, technological advancements, and aging population, which is more prone to cataract.
• Ophthalmic clinics in developing countries are working toward providing affordable eye care services, which in turn encourages the medical tourism in these countries. As a result, the demand for intraocular lenses is increasing in developing countries, thereby, driving market growth.
• Some key players are Bausch & Lomb Incorporation; Alcon Inc.; Johnson & Johnson Vision Care; Carl Zeiss Meditec AG.; MORCHER GmbH; and STAAR Surgical

Browse more reports of this category by Grand View Research at: www.grandviewresearch.com/industry/medical-devices

Grand View Research has segmented the global ocular implants market on the basis of product, application, end use, and region:

Ocular Implants Product Outlook (Revenue, USD Million, 2014 – 2025)

• Intraocular lenses
• Corneal implants
• Orbital implants
• Glaucoma implants
• Ocular prosthesis
• Others

Ocular Implants Application Outlook (Revenue, USD Million, 2014 – 2025)

• Glaucoma surgery
• Oculoplasty
• Drug delivery
• Age-related macular degeneration
• Aesthetic purpose

Ocular Implants End-use Outlook (Revenue, USD Million, 2014 – 2025)

• Hospitals
• Specialty eye institutes
• Clinics

Ocular Implants Regional Outlook (Revenue, USD Million, 2014 – 2025)

• North America
• Europe
• Asia Pacific
• Latin America
• MEA

Access Press Release of Ocular Implants Market @ www.grandviewresearch.com/press-release/global-ocular-implants-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Fluorescence In Situ Hybridization (FISH) Imaging Systems Market Size To Hit USD 1.4 Billion By 2025 : Grand View Research Inc.

San Francisco, 27 June 2019: The Report Fluorescence In Situ Hybridization (FISH) Imaging Systems Market Analysis By Product (Instruments, Microscopes, Automated Cell Analyzers, Services, Software), By Application, By End-use, And Segment Forecasts, 2018 – 2025

The global FISH imaging systems market is expected to reach USD 1.4 billion by 2025, according to a new report by Grand View Research, Inc. Increasing R&D investments pertaining to in vitro diagnostics are expected to drive the Fluorescence In Situ Hybridization (FISH) imaging systems market. Presence of government organizations, such as the European Diagnostic Manufacturers Association that focuses on development and growth of the in vitro diagnostics market in Europe, is also contributing to growth.

Furthermore, FISH imaging systems are gaining popularity in diagnostics for determination of suspected diseases caused by pathogens or bacteria. Increasing incidence of genetic diseases, such as lymphoma, solid tumors, leukemia, autism, and other developmental syndromes, is also expected to boost adoption. Growing penetration of fluoroscopy, microscopes, illuminators, and CCD cameras in testing for infectious diseases is expanding growth opportunities for these systems. Increasing prevalence of diseases with chromosomal aberrations, such as cancer and genetic abnormalities, as well as unmet diagnostic & clinical needs in developing countries, is anticipated to drive the market.

Moreover, increasing demand for rapid, sensitive, & accurate diagnostic techniques for validation of diseases, coupled with rising awareness, increase in healthcare expenditure, and extensive R&D for development of novel imaging systems are also expected to drive growth over the forecast period.

Access Research Report of Fluorescence In Situ Hybridization (FISH) Imaging Systems Market @ www.grandviewresearch.com/industry-analysis/fluorescence-in-situ-hybridization-fish-imaging-systems-market

Further Key Findings From the Report Suggest:

• Instruments held the largest market, whereas FISH imaging services are expected to grow at the fastest rate during the forecast period
• At present, the market penetration of FISH imaging in cancer diagnostics is very high, hence the diagnostic laboratories segment accounted for larger revenues
• Cancer diagnosis held the largest revenue share owing to increasing incidence of cancer, thus fueling adoption of FISH imaging systems
• Among end-use segments, companion diagnostics is expected to witness faster growth than research and diagnostic segments
• Diagnostic laboratories held the dominant position in 2016 as these systems are predominantly used in various clinical studies for visualization of precancerous lesions in cervical cancer, assessing risk of human papillomavirus, and for detection of leukemia, myelodysplastic syndrome, multiple myeloma, & chromosomal abnormalities
• North America held the largest revenue share owing to extensive adoption of these solutions in research and development across this region
• Asia Pacific is anticipated to exhibit lucrative CAGR over the forecast period due to increase in investments by manufacturers & governments, supportive government initiatives in the biotechnology sector, and presence of a large number of untapped opportunities
• The industry is highly competitive with a limited number of players holding a majority of the overall revenues. Some of the most notable market participants are Thermo Fisher Scientific, Inc. and General Electric Company. They account for a considerable share of the industry

Browse more reports of this category by Grand View Research at: www.grandviewresearch.com/industry/medical-devices

Grand View Research has segmented the global FISH imaging systems market on the basis of product, application, end use, and region:

FISH Imaging Systems Product Outlook (Revenue, USD Million, 2014 – 2025)

• Instruments
  • Microscopes
  • Automated cell analyzers
  • Others
• Consumables & Accessories
• Services
• Software

FISH Imaging Systems Application Outlook (Revenue, USD Million, 2014 – 2025)

• Cancer Diagnosis
  • Lung cancer
  • Breast cancer
  • Others
• Genetic Disease Diagnosis
• Others

FISH Imaging Systems End-use Outlook (Revenue, USD Million, 2014 – 2025)

• Diagnostic Laboratories
• Research & Academic Institutes
• Others

FISH Imaging Systems Regional Outlook (Revenue, USD Million, 2014 – 2025)

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Access Press Release of Fluorescence In Situ Hybridization (FISH) Imaging Systems Market @ www.grandviewresearch.com/press-release/global-fluorescence-in-situ-hybridization-fish-imaging-systems-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Personal Emergency Response System/Medical Alert System Market Is Estimated To Reach USD 11.1 Billion By 2025 : Grand View Research Inc.

San Francisco, 27 June 2019: The Report Personal Emergency Response System/Medical Alert System Market Analysis By Type (Landline, Mobile, Standalone), By End-use (Home-based Users, Nursing Homes, Assisted Living Facilities, Hospices), And Segment Forecasts, 2018 – 2025

The global PERS market is estimated to reach USD 11.1 billion by 2025, according to a new report by Grand View Research, Inc. Increasing incidence of Alzheimer’s disease and rising life expectancy are estimated to boost the market for Medical alert systems. Moreover, increasing number of mergers and acquisitions by market players are also expected to accelerate growth.

Furthermore, the elderly is more prone to falls, and according to a study, 50% of seniors aged 80 years and 30% of seniors aged 65 fall every year. In addition, those suffering from diseases such as epilepsy, Alzheimer’s, Parkinson’s, multiple sclerosis, and muscular dystrophy, are at a higher risk of falling. These are major factors that are estimated to drive the market.

In addition, availability of technologically advanced medical alert systems, such as those enabled with W-Fi, GPS, BLE, and radio frequency, help caregivers in finding wandering elders. Combination of PERS with mobile communication technology has enabled not only monitoring of users when they are at home, but also when they are traveling and leading active lives. Devices are now capable of predictive or automatic fall detection and connect the elderly to their caregivers and medical professionals. Increasing awareness about Internet of Things has presented a huge opportunity for medical alert systems to create connected homes. Thus, technologically advanced PERS devices have accelerated the growth of the market.

Access Research Report of Personal Emergency Response System/Medical Alert System Market @ www.grandviewresearch.com/industry-analysis/medical-alert-personal-emergency-response-system-pers-market

Further Key Findings From the Report Suggest:

• Standalone devices are expected to be one of the fastest growing segments over the forecast period owing to their accessibility and affordability
• Mobile systems were the largest segment in 2016 due to their widespread utilization
• Home-based users segment is estimated to be the fastest growing end-use segment over the forecast period and it was the largest end-use segment in 2016
• North America dominated the market in 2016 owing to local presence of key players and increasing number of mergers and acquisitions
• Asia Pacific is expected to be the fastest growing region over the next decade with a lucrative CAGR from 2017 to 2025 due to improved economic conditions and rise in healthcare expenditure
• Some of the key players are Koninklijke Philips N.V.; ADT Security Services; Bay Alarm Medical; VRI, Inc.; Life Alert Emergency Response, Inc.; Tunstall; Medical Guardian LLC; AlertOne Services LLC; GreatCall; Rescue Alert; LogicMark; and Nortek Security and Control
• Most of the key players are focusing on expanding their product portfolios, and engaging in collaborations and acquisitions

Browse more reports of this category by Grand View Research at: www.grandviewresearch.com/industry/healthcare-it

Grand View Research has segmented the global personal emergency response systems market on the basis of type, end-use, and region:

Type Outlook (Revenue, USD billion, 2014 – 2025)

• Landline PERS
• Mobile PERS
• Standalone PERS

End-use Outlook (Revenue, USD billion, 2014 – 2025)

• Home-based Users
• Nursing Homes
• Assisted Living Facilities
• Hospices

Regional Outlook (Revenue, USD billion, 2014 – 2025)

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Access Press Release of Personal Emergency Response System/Medical Alert System Market @ www.grandviewresearch.com/press-release/global-medical-alert-personal-emergency-response-system-pers-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com